Herbalife (HLF) Cash & Equivalents (2009 - 2026)

Herbalife (HLF) has 18 years of Cash & Equivalents data on file, last reported at $451.2 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 28.55% year-over-year to $451.2 million; the trailing twelve-month figure through Mar 2026 stood at $451.2 million (up 28.55% YoY), and the FY2025 full-year result was $353.1 million, down 19.4% from the prior year.
• Cash & Equivalents climbed to $451.2 million in Q1 2026, from $353.1 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $595.5 million in Q4 2023 to a low of $305.5 million in Q3 2025.
• A 5-year average of $458.0 million and a median of $451.2 million in 2026 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents sank 30.3% in 2022 and advanced 28.55% in 2026, its largest moves.
• Tracing HLF's Cash & Equivalents over 5 years: stood at $516.3 million in 2022, then advanced by 15.34% to $595.5 million in 2023, then dropped by 26.43% to $438.1 million in 2024, then declined by 19.4% to $353.1 million in 2025, then climbed by 27.78% to $451.2 million in 2026.
• Business Quant data shows HLF's Cash & Equivalents at $451.2 million in Q1 2026, $353.1 million in Q4 2025, and $305.5 million in Q3 2025.